Efficacy of Vonoprazan with Amoxicillin as the First Line Therapy for Helicobacter pylori Eradication in Asian Population: A Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Studies | Synapse
March 30, 2026Open Access
Efficacy of Vonoprazan with Amoxicillin as the First Line Therapy for Helicobacter pylori Eradication in Asian Population: A Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Studies
Key Points
This research assesses the effectiveness of vonoprazan combined with amoxicillin for eradicating Helicobacter pylori.
Conducted a systematic review and meta-analysis of clinical studies
Focused on Asian populations
Analyzed data for efficacy of the combination therapy
Vonoprazan with amoxicillin shows high eradication rates for H. pylori in Asia
Efficacy results indicate strong effectiveness compared to traditional therapies
Abstract
Vonoprazan with amoxicillin is effective as first-line therapy for H. pylori eradication in the Asian population.